ARTICLE | Clinical News
ThermoDox heat-activated liposome regulatory update
August 30, 2010 7:00 AM UTC
FDA granted Orphan Drug designation for Celsion's ThermoDox plus radiofrequency ablation (RFA) to treat non-resectable hepatocellular carcinoma (HCC). The doxorubicin encapsulated in a heat-activated ...